Skip to Content

Enzolytics Inc - Stock Quote ENZC

Rating as of

Morningstar's Enzolytics Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - ENZC

Enzolytics Inc's Company Profile

Business Description

Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies and an artificial intelligence (AI) platform for heath care developments. The Company has clinically tested anti HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.

2000 North Central Expressway
Plano, TX, 75074
T +1 972 292-9414
Industry Biotechnology
Most Recent Earnings Jun 30, 2011
Fiscal Year End Dec 31, 2022
Stock Type Distressed
Employees 1